Saudi Arabia Cancer Stem Cells Market Size & Outlook
Related Markets
Saudi Arabia cancer stem cells market highlights
- The Saudi Arabia cancer stem cells market generated a revenue of USD 19.9 million in 2023 and is expected to reach USD 33.2 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 7.3% from 2024 to 2030.
- In terms of segment, targeted cancerous stem cells (cscs) was the largest revenue generating mode of action in 2023.
- Targeted Cancerous Stem Cells (CSCs) is the most lucrative mode of action segment registering the fastest growth during the forecast period.
Cancer stem cells market data book summary
| Market revenue in 2023 | USD 19.9 million |
| Market revenue in 2030 | USD 33.2 million |
| Growth rate | 7.3% (CAGR from 2024 to 2030) |
| Largest segment | Targeted cancerous stem cells (cscs) |
| Fastest growing segment | Targeted Cancerous Stem Cells (CSCs) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Targeted Cancerous Stem Cells (CSCs), Stem Cell-based Cancer Therapy |
| Key market players worldwide | Thermo Fisher Scientific Inc, AbbVie Inc, Merck KGaA, Lonza Group Ltd, Bionomics Ltd ADR, Menarini Group, Miltenyi Biotec, PromoCell GmbH, Macrogenics Inc, FUJIFILM Holdings Corp, Stemcell Holdings Inc Ordinary Shares, Sino Biological, Lineage Logistics, Mereo BioPharma Group PLC ADR |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.5% of the global cancer stem cells market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia cancer stem cells market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 20.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Stem Cells Market Scope
Cancer Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Mereo BioPharma Group PLC ADR | View profile | 33 | One Cavendish Place, 4th Floor, London, United Kingdom, W1G 0QF | https://www.mereobiopharma.com |
| Menarini Group | View profile | 1001-5000 | Firenze, Toscana, Italy, Europe | http://www.menarini.com |
| Bionomics Ltd ADR | View profile | 8 | 200 Greenhill Road, Eastwood, SA, Australia, 5063 | https://www.bionomics.com.au |
| Lineage Logistics | View profile | 10001+ | Novi, Michigan, United States, North America | http://www.lineagelogistics.com |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.promocell.com/ |
| Macrogenics Inc | View profile | 339 | 9704 Medical Center Drive, Rockville, MD, United States, 20850 | https://www.macrogenics.com |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | http://www.miltenyibiotec.com |
| Sino Biological | View profile | 251-500 | Beijing, Beijing, China, Asia | http://www.sinobiological.com |
| Stemcell Holdings Inc Ordinary Shares | View profile | - | 1185 Avenue of the Americas, 3rd Floor, New York, NY, United States, 10036 | https://www.stemcell-holdings.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Saudi Arabia cancer stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer stem cells market will help companies and investors design strategic landscapes.
Targeted cancerous stem cells (cscs) was the largest segment with a revenue share of 74.37% in 2023. Horizon Databook has segmented the Saudi Arabia cancer stem cells market based on targeted cancerous stem cells (cscs), stem cell-based cancer therapy covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Saudi Arabia cancer stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia cancer stem cells market databook
-
Our clientele includes a mix of cancer stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia cancer stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia cancer stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia cancer stem cells market size, by targeted cancerous stem cells (cscs), 2018-2030 (US$M)
Saudi Arabia Cancer Stem Cells Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
